Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.08 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Black Diamond Therapeutics (BDTX) Price to Earnings (2025)

Updated

Black Diamond Therapeutics' (BDTX) Price to Earnings stood at 6.21 in Q4 2025, down 38.2% from the prior quarter.

Analysis

Black Diamond Therapeutics (BDTX) Price to Earnings (2025) Analysis & Trends

Starting with Q1 2025, Black Diamond Therapeutics' Price to Earnings history includes 4 quarters.

  • Per Business Quant, the preceding three quarters came in at 10.04 (Q3 2025), 9.77 (Q2 2025) and 17.26 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Black Diamond Therapeutics 119.49 Mn -373.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.21
Sep 30, 2025 10.04
Jun 30, 2025 9.77
Mar 31, 2025 17.26
API Access

Black Diamond Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=BDTX&period=max&api_key=YOUR_API_KEY